Download the free whitepaper: Unravelling the complexities of genomics-driven drug discovery
Genomics-driven drug discovery holds immense promise in developing targeted therapies by leveraging genetic and biomarker information to understand the root causes of diseases. However, the field faces significant hurdles.
In this whitepaper, we examine the obstacles of limited recontactability, scarcity of multi-omics data sets, lack of diversity in data, and the challenge of scaling research for rare diseases. By addressing these challenges and proposing strategies to address them, this whitepaper aims to chart a path by which we can harness the full potential of genomics-driven drug discovery.
Download whitepaper
The future of precision medicine in autoimmune and inflammatory disease: A strategic framework
Autoimmune and inflammatory diseases affect 1 in 10 people globally, and each person is affected differently. For pharma and biotech leaders, this complexity creates both a challenge and an important opportunity. Precision medicine offers a way forward, enabling more targeted, patient-centric treatments that minimize adverse effects and improve long-term outcomes.
This whitepaper outlines a strategic roadmap for delivering precision medicine in autoimmune and inflammatory disease. It explores the tools, infrastructure, and cross-sector collaboration needed to overcome clinical heterogeneity, accelerate therapeutic development, and support equitable access to care.
In this whitepaper, we explore:
🧬 A breakdown of current and emerging treatment approaches, including CRISPR and CAR-T.
🚧 Key barriers to innovation, including data fragmentation, regulatory challenges, and access gaps.
🌐 A practical framework for integrating precision medicine into R&D and clinical workflows.
📋 Insights on the role of real-world evidence, HEOR, and patient-centric trial design.
🚀 Future outlooks on investment trends and global innovation efforts.
Download the whitepaper now to explore the full framework.